-+ 0.00%
-+ 0.00%
-+ 0.00%

Xeris Biopharma Holdings Q4 Earnings Assessment

Benzinga·03/02/2026 12:02:18
Listen to the news

The earnings results for Xeris Biopharma Holdings (NASDAQ:XERS) for Q4 were made public on Monday, March 2, 2026 at 07:00 AM.

Here's a comprehensive overview of the announcement.

Earnings

Xeris Biopharma Holdings beat estimated earnings by 50.0%, reporting an EPS of $0.06 versus an estimate of $0.04.

Revenue was up $25.71 million from the same period last year.

Previous Earnings Records

Last quarter the company missed on EPS by $0.01 which was followed by a 3.63% drop in the share price the next day.

Here's a look at Xeris Biopharma Holdings's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.01 -0.03 -0.04 -0.02
EPS Actual 0 -0.01 -0.06 -0.03
Revenue Estimate 74.26M 64.75M 57.61M 58.54M
Revenue Actual 74.38M 71.54M 60.12M 60.10M

To track all earnings releases for Xeris Biopharma Holdings visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.